WMT

98.18

+0.38%↑

COST

985.76

-0.39%↓

KR

71.21

-0.68%↓

TGT

103.84

+5.19%↑

GIS

53.15

+2.53%↑

WMT

98.18

+0.38%↑

COST

985.76

-0.39%↓

KR

71.21

-0.68%↓

TGT

103.84

+5.19%↑

GIS

53.15

+2.53%↑

WMT

98.18

+0.38%↑

COST

985.76

-0.39%↓

KR

71.21

-0.68%↓

TGT

103.84

+5.19%↑

GIS

53.15

+2.53%↑

WMT

98.18

+0.38%↑

COST

985.76

-0.39%↓

KR

71.21

-0.68%↓

TGT

103.84

+5.19%↑

GIS

53.15

+2.53%↑

WMT

98.18

+0.38%↑

COST

985.76

-0.39%↓

KR

71.21

-0.68%↓

TGT

103.84

+5.19%↑

GIS

53.15

+2.53%↑

Search

USANA Health Sciences Inc

Closed

31.87 4.25

Overview

Share price change

24h

Current

Min

30.41

Max

32.3

Key metrics

By Trading Economics

Income

4.8M

9.3M

Sales

36M

250M

P/E

Sector Avg

16.775

40.441

EPS

0.73

Profit margin

3.723

Employees

1,700

EBITDA

11M

27M

Dividends

By Dow Jones

Next Earnings

22 lip 2025

Market Stats

By TradingEconomics

Market Cap

49M

569M

Previous open

27.62

Previous close

31.87

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

USANA Health Sciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

1 lip 2025, 23:09 UTC

Earnings

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

1 lip 2025, 19:16 UTC

Acquisitions, Mergers, Takeovers

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

1 lip 2025, 23:47 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

1 lip 2025, 23:41 UTC

Market Talk

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

1 lip 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

James Hardie: Deal Represents Implied Value of $8.4 Billion

1 lip 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

1 lip 2025, 22:21 UTC

Acquisitions, Mergers, Takeovers

James Hardie Completes Acquisition of AZEK

1 lip 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1 lip 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 lip 2025, 20:24 UTC

Earnings

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

1 lip 2025, 19:55 UTC

Market Talk

Oil Futures Resume Cautious Rally -- Market Talk

1 lip 2025, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Lose More Ground -- Market Talk

1 lip 2025, 19:12 UTC

Market Talk

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

1 lip 2025, 19:01 UTC

Acquisitions, Mergers, Takeovers

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

1 lip 2025, 18:41 UTC

Acquisitions, Mergers, Takeovers

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

1 lip 2025, 18:33 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

1 lip 2025, 18:33 UTC

Market Talk

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

1 lip 2025, 18:32 UTC

Market Talk

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

1 lip 2025, 18:22 UTC

Market Talk

Remittances to Mexico Down in May -- Market Talk

1 lip 2025, 17:45 UTC

Market Talk

Seasonal Demand Supports Further Oil Gains -- Market Talk

1 lip 2025, 17:01 UTC

Acquisitions, Mergers, Takeovers

Danone Completed Acquisition of Majority Stake in Kate Farms

1 lip 2025, 16:55 UTC

Earnings

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

1 lip 2025, 16:27 UTC

Market Talk

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

1 lip 2025, 16:25 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

1 lip 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

1 lip 2025, 15:48 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

1 lip 2025, 15:46 UTC

Market Talk

Global Equities Roundup: Market Talk

1 lip 2025, 15:46 UTC

Market Talk

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

1 lip 2025, 14:54 UTC

Market Talk

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

1 lip 2025, 14:49 UTC

Market Talk

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Peer Comparison

Price change

USANA Health Sciences Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

28.405 / 29.84Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

No Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.